Nhanganyaya Munzvimbo yeoncology, immunotherapy yabuda senzira yekutanga, ichishandisa immune system yemuviri kurwisa mapundu akaipa. Kune akawanda immunotherapeutic nzira, asi Chimeric Antigen Rece.
Sept 2022: European Commission (EC) yakabvumidza Kite's CAR T-cell therapy Tecartus® (brexucabtagene autoleucel) yekurapa varwere vakuru vane makore makumi maviri nematanhatu ekuberekwa zvichikwira vane kudzokazve kana kuramba (r/r) B-cell precurs.
Gumiguru 2021: Brexucabtagene autoleucel (Tecartus, Kite Pharma, Inc.) yakabvumidzwa neFood and Drug Administration yevarwere vakuru vane kudzoka kana kuramba B-cell precursor acute lymphoblastic leukemia (ALL). Mu..
Chikunguru 2021: Tarisa uone mishonga ichangoburwa mukurapa cancer. Gore rega rega, mushure mekuongorora miedzo uye zvimwe zvakakosha, USFDA inobvumidza mishonga, uye nekudaro varwere vegomarara vanogona kutenda kuti kurapwa kwave pedyo. ..